Ambev S.A (ABEVN)
Mexican Exchange · Mexico · prices in MXN · close of 19 Oct 2026
Key indicators
| Last close | MXN 59.10 |
|---|---|
| 52-week range | 40.66 – 59.10 |
| Return, 1 month / 3 months | +13.6% / +10.3% |
| Return, 1 year / 3 years | +46.6% / +45.3% |
| Trend | Uptrend |
| RSI (14) | 89 |
| Volatility (1 year) | 37.9% |
| Worst drawdown (1 year) | -16.3% |
| Average daily value traded | 0.85M MXN |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ambev is a beverage company based in Brazil that brews and distributes beer and produces soft drinks and other non-alcoholic beverages. Its beer brands include Skol, Brahma and Antarctica, and it also makes carbonated drinks, bottled water and juices. The company serves consumers and retailers across Brazil and other Latin American markets through a large distribution network, and it operates as part of the Anheuser-Busch InBev group.
Ambev S.A trades under the code ABEVN on the Mexican Exchange in Mexico, with its price quoted in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ambev S.A (ABEVN) trades on the Mexican Exchange in Mexico. It last closed at MXN 59.10 on 19 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 148 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 46.6% and over the last three months it rose 10.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 12.9% | ||
| From 52-week high | 0.0% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.3% | ||
| 6-month return | 6.0% | ||
| 12-month return, skipping the last month | 29.1% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.3% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.85M MXN | ||
| Zero-volume days | 81.7% | ||
| Income | 31 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +13.6% |
| 3 months | +10.3% |
| 6 months | +6.0% |
| 1 year | +46.6% |
| 3 years | +45.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 51.95 / 52.36 |
|---|---|
| Golden / death cross (60 days) | Death, 15 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Dec 2025 | MXN 0.7495 |
| 11 Aug 2025 | MXN 0.4479 |
| 19 May 2025 | MXN 0.4582 |
| 18 Mar 2025 | MXN 0.4480 |
| 23 Dec 2024 | MXN 0.8019 |
| 22 Dec 2023 | MXN 2.1773 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.